Posted in | News | Lead | Zinc

Kobex Minerals to Perform 2012 Exploration Program on Mel Zinc-Lead- Barite Property

During the 2012 exploration field season, Kobex Minerals has planned to perform a drilling and soil geochemical sampling campaign on its Mel Zinc-Lead-Barite property in Yukon Territory.

The Mel exploration campaign includes 1245 m of diamond drilling on the Mel East, Jeri and Main Mel zones.

The aim of the drill campaign is to analyze the geophysical targets that are situated beneath the prior identified zinc-lead mineralization at the Mel East and Jeri zones. Additionally, on the Main Mel zone, the down dip continuity to mineralization will also be tested. Indicated mineral resource of 6.78 M t of 54.69% barite, 2.03% lead and 7.1% zinc was previously reported on the Main Mel zone.

Besides the drill campaign, the company will perform a soil geochemical survey to study four known zinc-lead geochemical anomalies that are situated in potential geology on strike towards north of the Jeri North zone.

Kobex Minerals’ President, A.L. Hills commented that the company has completed the assessment, data and re-analysis of drill hole information on the Mel property. In view of favorable location in the Yukon, the emerging popularity of zinc, exploration potential, and present indicated mineral resource of the Mel property, the company has decided to assess this property through the reconnaissance campaign.

Hills further added that at present, the company has about 37 million dollars and it is looking for acquisition opportunities so as to purchase projects that meet its standards of competitive costs, established resources, and significant exploration.

The Mel property includes 257 claims and lies 80 km north-northeast of Watson Lake in Yukon Territory and about 50 km from the Alaska Highway.

Source: http://www.kobexminerals.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Kobex Minerals to Perform 2012 Exploration Program on Mel Zinc-Lead- Barite Property. AZoMining. Retrieved on April 24, 2024 from https://www.azomining.com/News.aspx?newsID=6330.

  • MLA

    Scanlon, Joel. "Kobex Minerals to Perform 2012 Exploration Program on Mel Zinc-Lead- Barite Property". AZoMining. 24 April 2024. <https://www.azomining.com/News.aspx?newsID=6330>.

  • Chicago

    Scanlon, Joel. "Kobex Minerals to Perform 2012 Exploration Program on Mel Zinc-Lead- Barite Property". AZoMining. https://www.azomining.com/News.aspx?newsID=6330. (accessed April 24, 2024).

  • Harvard

    Scanlon, Joel. 2019. Kobex Minerals to Perform 2012 Exploration Program on Mel Zinc-Lead- Barite Property. AZoMining, viewed 24 April 2024, https://www.azomining.com/News.aspx?newsID=6330.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.